IL160851A0 - Thiopene-and thiazolesulfonamides as antineoplastic agents - Google Patents

Thiopene-and thiazolesulfonamides as antineoplastic agents

Info

Publication number
IL160851A0
IL160851A0 IL16085102A IL16085102A IL160851A0 IL 160851 A0 IL160851 A0 IL 160851A0 IL 16085102 A IL16085102 A IL 16085102A IL 16085102 A IL16085102 A IL 16085102A IL 160851 A0 IL160851 A0 IL 160851A0
Authority
IL
Israel
Prior art keywords
thiazolesulfonamides
thiopene
antineoplastic agents
antineoplastic
agents
Prior art date
Application number
IL16085102A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL160851A0 publication Critical patent/IL160851A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16085102A 2001-10-25 2002-10-15 Thiopene-and thiazolesulfonamides as antineoplastic agents IL160851A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35201201P 2001-10-25 2001-10-25
PCT/US2002/031568 WO2003035629A1 (en) 2001-10-25 2002-10-15 Thiopene- amd thiazolesulfonamides as antineoplastic agents

Publications (1)

Publication Number Publication Date
IL160851A0 true IL160851A0 (en) 2004-08-31

Family

ID=23383421

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16085102A IL160851A0 (en) 2001-10-25 2002-10-15 Thiopene-and thiazolesulfonamides as antineoplastic agents
IL160851A IL160851A (en) 2001-10-25 2004-03-11 Thiophene-and thiazolesulfonamide compounds, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for treating susceptible neoplasms

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160851A IL160851A (en) 2001-10-25 2004-03-11 Thiophene-and thiazolesulfonamide compounds, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for treating susceptible neoplasms

Country Status (34)

Country Link
US (2) US7084170B2 (xx)
EP (1) EP1442030B1 (xx)
JP (1) JP4464681B2 (xx)
KR (1) KR100913471B1 (xx)
CN (1) CN1298709C (xx)
AR (1) AR037248A1 (xx)
AT (1) ATE338033T1 (xx)
AU (1) AU2002334817B2 (xx)
BR (1) BR0212386A (xx)
CA (1) CA2463300C (xx)
CY (1) CY1106247T1 (xx)
DE (1) DE60214413T2 (xx)
DK (1) DK1442030T3 (xx)
EA (1) EA006081B1 (xx)
EC (1) ECSP045078A (xx)
EG (1) EG26021A (xx)
ES (1) ES2269816T3 (xx)
HK (1) HK1068337A1 (xx)
HR (1) HRP20040371B1 (xx)
HU (1) HUP0401638A3 (xx)
IL (2) IL160851A0 (xx)
MX (1) MXPA04003886A (xx)
MY (1) MY130718A (xx)
NO (1) NO20041316L (xx)
NZ (1) NZ531136A (xx)
PE (1) PE20030574A1 (xx)
PL (1) PL208083B1 (xx)
PT (1) PT1442030E (xx)
SI (1) SI1442030T1 (xx)
SV (1) SV2004001367A (xx)
TW (1) TWI281916B (xx)
UA (1) UA75716C2 (xx)
WO (1) WO2003035629A1 (xx)
ZA (1) ZA200403089B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1401825E (pt) * 2001-06-11 2009-10-23 Virochem Pharma Inc Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
EP1532133A4 (en) * 2002-06-06 2006-11-15 Smithkline Beecham Corp NF-: B INHIBITORS
US7402608B2 (en) * 2002-12-10 2008-07-22 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of Flavivirus infections
SE0300091D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300092D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
EP2364699A1 (en) * 2004-09-13 2011-09-14 Eisai R&D Management Co., Ltd. Joint use of sulfonamide based compound with angiogenesis inhibitor
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
EP1859793B1 (en) 2005-02-28 2011-04-20 Eisai R&D Management Co., Ltd. Novel combinational use of a sulfonamide compound in the treatment of cancer
WO2006090921A1 (ja) * 2005-02-28 2006-08-31 Eisai R & D Management Co., Ltd. スルホンアミド化合物のリンパ球活性化抑制作用
JPWO2006090928A1 (ja) * 2005-02-28 2008-07-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド化合物の血管新生阻害物質との新規併用
CA2607359C (en) * 2005-05-13 2011-08-09 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of flavivirus infections
US7208506B2 (en) 2005-07-07 2007-04-24 Hoffmann-La Roche Inc. Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
US7625896B2 (en) * 2005-11-25 2009-12-01 Hoffman-La Roche Inc. Pyridylsulfonamide derivatives
US20100291592A1 (en) 2006-04-20 2010-11-18 Taro Semba Novel marker for sensitivity against sulfonamide compound
US7939532B2 (en) 2006-10-26 2011-05-10 Hoffmann-La Roche Inc. Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
BRPI0718915A2 (pt) 2006-11-15 2013-12-03 Virochem Pharma Inc Análogos de tiofeno para o tratamento ou prevenção de infecções por flavivírus
US7879884B2 (en) 2007-05-16 2011-02-01 Hoffmann-La Roche Inc. Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
CN101899008B (zh) * 2010-05-20 2012-10-17 中国人民解放军第二军医大学 N-取代嘧啶磺酰基-取代苯甲酰胺类化合物及其制备药物的用途
CN103450149B (zh) * 2012-06-01 2015-10-14 中国科学院上海有机化学研究所 苯基噻吩磺酰胺类化合物及其制备方法和用途
JP6364967B2 (ja) * 2014-05-30 2018-08-01 東ソー株式会社 ジチエノベンゾジチオフェンの製造方法
CN106588868A (zh) * 2016-11-16 2017-04-26 武汉理工大学 一种2‑溴‑3‑噻吩甲酸中间体的合成方法
CN108558822B (zh) * 2018-06-01 2020-12-18 盐城锦明药业有限公司 N-((5-溴噻吩-2-基)磺酰基)-2,4-二氯苯甲酰胺的合成方法
CN110835345A (zh) * 2018-08-17 2020-02-25 中国科学院上海药物研究所 一类细胞周期依赖性激酶的降解剂、其制备方法、药物组合物及其用途
CN109265437A (zh) * 2018-10-19 2019-01-25 凯莱英医药集团（天津）股份有限公司 一种3-羟基噻吩-2-羧酸酯类化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA813332B (en) * 1980-06-21 1982-05-26 Pfizer Larvicides and isecticides
IL98784A0 (en) * 1990-07-17 1992-07-15 Lilly Co Eli Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them
US5177074A (en) * 1991-03-26 1993-01-05 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
AU737038B2 (en) * 1996-07-05 2001-08-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
AU4799797A (en) 1996-10-04 1998-04-24 Eli Lilly And Company Antitumor compositions and methods of treatment
JP4316787B2 (ja) 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、

Also Published As

Publication number Publication date
US7084170B2 (en) 2006-08-01
CA2463300A1 (en) 2003-05-01
TWI281916B (en) 2007-06-01
US20040198784A1 (en) 2004-10-07
AU2002334817B2 (en) 2008-02-21
JP4464681B2 (ja) 2010-05-19
IL160851A (en) 2009-11-18
HUP0401638A3 (en) 2012-09-28
HUP0401638A2 (hu) 2004-11-29
US7250430B2 (en) 2007-07-31
EP1442030B1 (en) 2006-08-30
CY1106247T1 (el) 2011-06-08
CA2463300C (en) 2011-07-19
ES2269816T3 (es) 2007-04-01
ECSP045078A (es) 2004-06-28
BR0212386A (pt) 2004-07-27
CN1575286A (zh) 2005-02-02
PE20030574A1 (es) 2003-07-03
DE60214413T2 (de) 2007-03-08
MY130718A (en) 2007-07-31
PT1442030E (pt) 2006-12-29
EA006081B1 (ru) 2005-08-25
HRP20040371A2 (en) 2004-08-31
DK1442030T3 (da) 2006-12-27
ATE338033T1 (de) 2006-09-15
MXPA04003886A (es) 2004-07-08
JP2005511547A (ja) 2005-04-28
EP1442030A1 (en) 2004-08-04
NZ531136A (en) 2006-08-31
DE60214413D1 (de) 2006-10-12
EA200400582A1 (ru) 2004-08-26
AR037248A1 (es) 2004-11-03
SV2004001367A (es) 2004-02-24
HRP20040371B1 (en) 2012-07-31
PL208083B1 (pl) 2011-03-31
SI1442030T1 (sl) 2006-12-31
EG26021A (en) 2012-12-10
HK1068337A1 (en) 2005-04-29
US20060223871A1 (en) 2006-10-05
ZA200403089B (en) 2005-04-22
PL368234A1 (en) 2005-03-21
KR20040062583A (ko) 2004-07-07
CN1298709C (zh) 2007-02-07
NO20041316L (no) 2004-03-30
KR100913471B1 (ko) 2009-08-25
UA75716C2 (en) 2006-05-15
WO2003035629A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
HK1068337A1 (en) Thiopene- amd thiazolesulfonamides as antineoplastic agents
HK1061204A1 (en) Antineoplastic combinations
ZA200603888B (en) Antineoplastic combinations
IL158800A0 (en) Antineoplastic combinations
AU2002360430A8 (en) 14-methyl-epothilones
IL160539A0 (en) Anti-influenzal agents
GB0125492D0 (en) Formulation
AU2002313943A8 (en) Electromobile
GB2396812B (en) Formulation
GB2375048B (en) Formulation
GB0116619D0 (en) Formulation
AU2001100134A4 (en) Enviro-trap
GB0112497D0 (en) Formulation
CA93646S (en) Fauteuil
CA92665S (en) Bedboard
AU2479P (en) Crackerjack xTriticosecale
CA93647S (en) Fauteuil
AU2288P (en) Prime322 xTriticosecale
CA93127S (en) Tilt-latch
CA93126S (en) Titlt-latch
CA93125S (en) Tilt-latch
CA93075S (en) Travelbag
CA92978S (en) Photo-changer
CA93959S (en) Tilt-latch
CA91502S (en) Bedboard